Brg1抑制通过减弱祖细胞扩增预防肝纤维化与胆管癌
该研究探讨Brg1在肝祖细胞扩增、肝纤维化及肝内胆管癌中的作用。回顾性队列显示Brg1高表达提示iCCA预后不良;慢性肝损伤模型中HPCs的Brg1表达增强,而Brg1敲除抑制HPC扩增和肝纤维化;化学诱导iCCA模型中Brg1抑制或基因敲除改善组织学并抑制肿瘤生长,机制涉及Wnt/β-catenin信号。
要点
- Brg1高表达与iCCA患者预后不良相关。
- HPCs中Brg1敲除抑制祖细胞扩增和肝纤维化。
- 靶向Brg1表达HPCs可能治疗肝硬化和iCCA。
核心结论
- Brg1促进慢性损伤肝脏中HPC扩增、肝硬化和iCCA发展,主要依赖Wnt/β-catenin信号。
研究设计与样本
- 回顾性队列研究分析iCCA患者Brg1表达与预后。
- 使用0.1% DDC饮食或胆管结扎手术诱导慢性肝损伤模型。
- 使用化学诱导iCCA模型,采用Brg1特异性抑制剂或诱导性基因敲除。
主要发现
- 回顾性队列显示iCCA患者中Brg1高表达提示预后不良。
- 慢性肝损伤模型中HPCs的Brg1和干细胞标志物表达增强。
- HPCs中Brg1敲除强烈抑制HPC扩增和肝纤维化。
- 化学诱导iCCA模型中Brg1抑制或基因敲除改善组织学并抑制iCCA生长。
- Brg1转录促进Wnt受体基因和靶基因,并结合β-catenin/TCF4转录复合物。
临床怎么用
- 靶向Brg1表达HPCs可能成为治疗肝硬化和iCCA的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma (iCCA) is closely correlated with hepatic progenitor cell (HPC) expansion and liver fibrosis. Brahma-related gene 1 (Brg1), an enzymatic subunit of the switch/sucrose nonfermentable complex that is critical in stem cell maintenance and tumor promotion, is prominently up-regulated in both HPCs and iCCA; however, its role in this correlation remains undefined. APPROACH AND RESULTS: A retrospective cohort study indicated that high Brg1 expression suggests poor prognosis in patients with iCCA. In chronically injured livers induced by a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet or bile duct ligation surgery, HPCs were dramatically activated, as indicated by their enhanced expression of Brg1 and a subset of stem cell markers; however, Brg1 ablation in HPCs strongly suppressed HPC expansion and liver fibrosis. Furthermore, in a chemically induced iCCA model, inhibition of Brg1 by a specific inhibitor or inducible gene ablation markedly improved histology and suppressed iCCA growth. Mechanistically, in addition to transcriptionally promoting both Wnt receptor genes and target genes, Brg1 was found to bind to the β-catenin/transcription factor 4 transcription complex, suggesting a possible approach for regulation of Wnt/β-catenin signaling. CONCLUSIONS: We have demonstrated the function of Brg1 in promoting HPC expansion, liver cirrhosis, and, ultimately, iCCA development in chronically injured livers, which is largely dependent on Wnt/β-catenin signaling. Our data suggest that therapies targeting Brg1-expressing HPCs are promising for the treatment of liver cirrhosis and iCCA.
引用
- Zhou Y, Chen Y, Zhang X, et al. Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology. 2021. PMID: 33650193. doi:10.1002/hep.31780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。